Skip to content
Home/Companies/Biotech/Lipigon

Lipigon

Biotech·Sweden·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns Lipigon?

Lipigon is a Swedish Biotech company, formerly owned by Almi Invest, exited in 2021 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Almi Invest
Investor
Almi Invest
Almi Invest (Regional funds) · 2009 · VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2021

More from Almi Invest (Regional funds)

Other portfolio companies in the same fund.

Cellevate
Active
BiotechSweden· 2026
CubaseBio
Active
BiotechSweden· 2026
DAJE Prevent
Active
MedTechSweden· 2026
Permitify
Active
SaaSSweden· 2026
Radar Reticence
Active
SoftwareSweden· 2026
Rivus
Active
SoftwareSweden· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Lipigon?

Lipigon was formerly owned by Almi Invest, exited in 2021. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue